Quality of life and patient preferences among Danish patients with ulcerative colitis – results from a survey study

References

• Ordás I, Eckmann L, Talamini M, et al. Ulcerative colitis. Lancet. 2012;380(9853):1606–1619.
   PubMed Web of Science ®Google Scholar
• Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011;365(18):1713–1725.
   PubMed Web of Science ®Google Scholar
• Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54.e42. quiz e30.
   PubMed Web of Science ®Google Scholar
• RADS. Baggrundsnotat for dyre lægemidler til behandling af kroniske inflammatoriske tarmsygdomme [Background note for expensive drugs for the treatment of chronic inflammatory bowel diseases]. Danish; 2016.
   Google Scholar
• Knowles SR, Graff LA, Wilding H, et al. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses—part I. Inflamm Bowel Dis. 2018;24(4):742–751.
   PubMed Web of Science ®Google Scholar
• Knowles SR, Keefer L, Wilding H, et al. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses—part II. Inflamm Bowel Dis. 2018;24(5):966–976.
   PubMed Web of Science ®Google Scholar
• Bastemeijer CM, Voogt L, van Ewijk JP, et al. What do patient values and preferences mean? A taxonomy based on a systematic review of qualitative papers. Patient Educ Couns. 2017;100(5):871–881.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Coello PA, Brożek J, et al. Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach. Health Qual Life Outcomes. 2017;15(1):52.
   PubMed Web of Science ®Google Scholar
• Postmus D, Mavris M, Hillege HL, et al. Incorporating patient preferences into drug development and regulatory decision making: results from a quantitative pilot study with cancer patients, carers, and regulators. Clin Pharmacol Ther. 2016;99(5):548–554.
   PubMed Web of Science ®Google Scholar
• Ho M, Saha A, McCleary KK, et al. A framework for incorporating patient preferences regarding benefits and risks into regulatory assessment of medical technologies. Value Health. 2016;19(6):746–750.
   PubMed Web of Science ®Google Scholar
• Dassopoulos T, Cohen RD, Scherl EJ, et al. Ulcerative colitis care pathway. Gastroenterology. 2015;149(1):238–245.
   PubMed Web of Science ®Google Scholar
• Gray JR, Leung E, Scales J. Treatment of ulcerative colitis from the patient’s perspective: a survey of preferences and satisfaction with therapy. Aliment Pharmacol Ther. 2009;29(10):1114–1120.
   PubMed Web of Science ®Google Scholar
• Hodgkins P, Swinburn P, Solomon D, et al. Patient preferences for first-line oral treatment for mild-to-moderate ulcerative colitis: a discrete-choice experiment. Patient. 2012;5(1):33–44.
   PubMedGoogle Scholar
• Bewtra M, Kilambi V, Fairchild AO, et al. Patient preferences for surgical versus medical therapy for ulcerative colitis. Inflamm Bowel Dis. 2014;20(1):103–114.
   PubMed Web of Science ®Google Scholar
• Casellas F, Herrera-de Guise C, Robles V, et al. Patient preferences for inflammatory bowel disease treatment objectives. Dig Liver Dis. 2017;49(2):152–156.
   PubMedGoogle Scholar
• Schreiber S, Panés J, Louis E, et al. Perception gaps between patients with ulcerative colitis and healthcare professionals: an online survey. BMC Gastroenterol. 2012;12(1):108.
   PubMed Web of Science ®Google Scholar
• Rubin DT, Siegel CA, Kane SV, et al. Impact of ulcerative colitis from patients’ and physicians’ perspectives: results from the UC: NORMAL survey. Inflamm Bowel Dis. 2009;15(4):581–588.
   PubMed Web of Science ®Google Scholar
• Lönnfors S, Vermeire S, Greco M, et al. IBD and health-related quality of life – discovering the true impact. J Crohns Colitis. 2014;8(10):1281–1286.
   PubMed Web of Science ®Google Scholar
• Johnson R, Lancsar E, Marshall D, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health. 2013;16:3–13.
   PubMed Web of Science ®Google Scholar
• Devlin NJ, Brooks R. EQ-5D and the EuroQol Group: past, present and future. Appl Health Econ Health Policy. 2017;15(2):127–137.
   PubMed Web of Science ®Google Scholar
• Devlin NJ, Shah KK, Feng Y, et al. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ. 2018;27(1):7–22.
   PubMed Web of Science ®Google Scholar
• Sørensen J, Davidsen M, Gudex C, et al. Danish EQ-5D population norms. Scand J Public Health. 2009;37(5):467–474.
   PubMed Web of Science ®Google Scholar
• Jowett SL, Seal CJ, Barton JR, et al. The Short Inflammatory Bowel Disease Questionnaire is reliable and responsive to clinically important change in ulcerative colitis. Am J Gastroenterol. 2001;96(10):2921–2928.
   PubMed Web of Science ®Google Scholar
• Ryan M, Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ. 2000;320(7248):1530–1533.
   PubMed Web of Science ®Google Scholar
• Kappelman MD, Long MD, Martin C, et al. Evaluation of the patient-reported outcomes measurement information system in a large cohort of patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2014;12(8):1315–1323.e2.
   PubMed Web of Science ®Google Scholar
• Burisch J, Weimers P, Pedersen N, et al. Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease — an ECCO-EpiCom study. J Crohns Colitis. 2014;8(9):1030–1042.
   PubMed Web of Science ®Google Scholar
• Van Assche G, Peyrin-Biroulet L, Sturm A, et al. Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months – Multicenter European cohort study. Dig Liver Dis. 2016;48(6):592–600.
   PubMedGoogle Scholar
• Kodate N. Events, public discourses and responsive government: quality assurance in health care in England, Sweden and Japan. J Pub Pol. 2010;30(3):263–289.
   Web of Science ®Google Scholar
• Kawalec P, Stawowczyk E, Mossakowska M, et al. Disease activity, quality of life, and indirect costs of ulcerative colitis in Poland. Prz Gastroenterol. 2017;12:60–65.
   PubMed Web of Science ®Google Scholar
• Nedelciuc O, Pintilie I, Dranga M, et al. Quality of life in patients with ulcerative colitis. Rev Med Chir Soc Med Nat Iasi. 2012;116(3):756–760.
   PubMedGoogle Scholar
• Zahn A, Hinz U, Karner M, et al. Health-related quality of life correlates with clinical and endoscopic activity indexes but not with demographic features in patients with ulcerative colitis. Inflamm Bowel Dis. 2006;12(11):1058–1067.
   PubMed Web of Science ®Google Scholar
• Panés J, Domènech E, Peris MA, et al. Association between disease activity and quality of life in ulcerative colitis: results from the CRONICA-UC study. J Gastroenterol Hepatol. 2017;32(11):1818–1824.
   PubMed Web of Science ®Google Scholar
• Wan SW, He H-G, Mak A, et al. Health-related quality of life and its predictors among patients with rheumatoid arthritis. Appl Nurs Res. 2016;30:176–183.
   PubMed Web of Science ®Google Scholar
• Anyfanti P, Triantafyllou A, Panagopoulos P, et al. Predictors of impaired quality of life in patients with rheumatic diseases. Clin Rheumatol. 2016;35(7):1705–1711.
   PubMed Web of Science ®Google Scholar
• Hoshi D, Tanaka E, Igarashi A, et al. Profiles of EQ-5D utility scores in the daily practice of Japanese patients with rheumatoid arthritis; analysis of the IORRA database. Mod Rheumatol. 2016;26(1):40–45.
   PubMed Web of Science ®Google Scholar
• Hernández Alava M, Wailoo A, Wolfe F, et al. The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis. Rheumatology. 2013;52(5):944–950.
   PubMed Web of Science ®Google Scholar
• Cho S-K, Kim D, Jun J-B, et al. Factors influencing quality of life (QOL) for Korean patients with rheumatoid arthritis (RA). Rheumatol Int. 2013;33(1):93–102.
   PubMed Web of Science ®Google Scholar
• Kawalec P, Malinowski KP, Pilc A. Disease activity, quality of life and indirect costs of psoriatic arthritis in Poland. Rheumatol Int. 2016;36(9):1223–1230.
   PubMed Web of Science ®Google Scholar
• Michelsen B, Uhlig T, Sexton J, et al. Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls. Ann Rheum Dis. 2018;77(9):1290–1294.
   PubMed Web of Science ®Google Scholar
• Carneiro C, Chaves M, Verardino G, et al. Evaluation of fatigue and its correlation with quality of life index, anxiety symptoms, depression and activity of disease in patients with psoriatic arthritis. Clin Cosmet Investig Dermatol. 2017;10:155–163.
   PubMed Web of Science ®Google Scholar
• Gratacós J, Daudén E, Gómez-Reino J, et al. Health-related quality of life in psoriatic arthritis patients in Spain. Reumatol Clín (English Edition). 2014;10(1):25–31.
   Google Scholar
• Gregor JC, Williamson M, Dajnowiec D, et al. Inflammatory bowel disease patients prioritize mucosal healing, symptom control, and pain when choosing therapies: results of a prospective cross-sectional willingness-to-pay study. Patient Prefer Adherence. 2018;12:505–513.
   PubMed Web of Science ®Google Scholar
• Kornbluth A, Sachar DB, Practice Parameters Committee of The American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105(3):501–523, quiz 524.
   PubMed Web of Science ®Google Scholar
• Harbord M, Eliakim R, Bettenworth D, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management. J Crohns Colitis. 2017;11(7):769–784.
   PubMed Web of Science ®Google Scholar
• Dansk Selskab for Gastroenterologi og Hepatologi (DSGH). Akut svær coltitis ulcerosa [Acute severe ulcerative colitis]. Danish; 2016.
   Google Scholar
• Probert C. Steroids and 5-aminosalicylic acids in moderate ulcerative colitis: addressing the dilemma. Ther Adv Gastroenterol. 2013;6(1):33–38.
   PubMed Web of Science ®Google Scholar
• Alten R, Krüger K, Rellecke J, et al. Examining patient preferences in the treatment of rheumatoid arthritis using a discrete-choice approach. Patient Prefer Adherence. 2016;10:2217–2228.
   PubMed Web of Science ®Google Scholar
• Torbica A, Fattore G, Ayala F. Eliciting preferences to inform patient-centred policies: the case of psoriasis. Pharmacoeconomics. 2014;32(2):209–223.
   PubMed Web of Science ®Google Scholar
• Rasmussen R, Hjarsbech P. Oplevelser af behandlingsforløb og sygdomskonsekvenser blandt nuværende medlemmer af Colitis-Crohn Foreningen [Experiences of treatment and disease consequences among current members of the Colitis-Crohn Foreningen]. Danish: KORA; 2016.
   Google Scholar
• Tervonen T, Gelhorn H, Sri Bhashyam S, et al. MCDA swing weighting and discrete choice experiments for elicitation of patient benefit-risk preferences: a critical assessment. Pharmacoepidemiol Drug Saf. 2017;26(12):1483–1491.
   PubMed Web of Science ®Google Scholar
• Bateman IJ, Carson RT, Day B, et al. Economic valuation with stated preference techniques: a manual. Cheltenham (UK): Edward Elgar; 2002.
   Google Scholar
• Naik G, Ahmed H, Edwards A. Communicating risk to patients and the public. Br J Gen Pract. 2012;62(597):213–216.
   PubMed Web of Science ®Google Scholar